Skip to content
Partners4Access
Expert global consultancy specializing in access for orphan drugs
Partners4Access
  • Home
  • About us
    • Press releases
    • Meet the team
    • Careers
  • Services
  • Case studies
    • Case Study #1
    • Case Study #2
    • Case Study #3
  • Enlightened Opinion
    • Publications/White Papers
    • Webinars
  • Resources
    • Gene Therapy Mind Map
    • Podcasts
    • Blogs
  • Contact
Search:
  • Home
  • About us
    • Press releases
    • Meet the team
    • Careers
  • Services
  • Case studies
    • Case Study #1
    • Case Study #2
    • Case Study #3
  • Enlightened Opinion
    • Publications/White Papers
    • Webinars
  • Resources
    • Gene Therapy Mind Map
    • Podcasts
    • Blogs
  • Contact

Daily Archives: May 23, 2018

You are here:
  1. Home
  2. 2018
  3. May
  4. 23

What does the new FDA accelerated regulatory pathway mean for gene therapies?

Publications/White PapersBy partnersadminMay 23, 2018

U.S. Food and Drug Administration (FDA) commissioner Scott Gottlieb has announced that the drug agency is developing a system by which innovative gene therapies could be sped through the regulatory process. In a speech to board members of the Alliance for Regenerative Medicine, Dr. Gottlieb spoke about the challenges associated with reviewing cell and gene…

TwitterInstagramLinkedin

All Rights Reserved © Privacy Partners 4 Access 2020

Go to Top